Products

Signal Tracker Data Platform Data Enrichment API Intelligence desk

Solutions

Inward Investment & Aftercare Deal Origination Executive Search Corporate Development Signal-Based Outbound Competitive Intelligence Funding Signals Competitor Monitoring For Sales Teams For Founders For Agencies For Investors

Explore

Companies Live Signals Markets Trends

Resources

Signal Checker Blog Integrations FAQ Contact
Login Book a demo
AVVie logo — Advancing Transcatheter Mitral Valve Repair

AVVie

Advancing Transcatheter Mitral Valve Repair

Founded 2018 Austria Austria 9 employees Grant Health Care, Manufacturing +1

General Information

Company Name AVVie
Founded Year 2018
Location Austria Austria
Employees 9
Industries Health Care, Manufacturing, Medical Devices
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with AVVie. To contact AVVie, visit angelvalve.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does AVVie compare?

A PDF of AVVie and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting AVVie soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About AVVie

AVVie is a health care startup based in Austria, founded in 2018, dedicated to addressing the unmet medical need of mitral valve regurgitation (MR) and subsequent heart failure. With a mission to advance transcatheter mitral valve repair, AVVie has developed the Mitral Butterfly (MB) system. This innovative solution aims to cater to the significant gap in treatment for MR, as currently, less than 5% of moderately to severely ill patients receive treatment. The Mitral Butterfly serves as a hemi valve, effectively replacing the function of the dysfunctional posterior leaflet while preserving the motion and function of the anterior leaflet. The system, utilizing a nitinol-based frame and a pericardial membrane, is designed to restore full coaptation and prevent unphysiological inflow, with the flexibility of delivery through minimally invasive surgery or transseptal delivery. AVVie operates in the medical devices and manufacturing industries, offering a potentially game-changing solution in the cardiology space. Currently, there is no public information available regarding the last investment and associated investors for AVVie.

No funding data available for AVVie yet.

AVVie Alternatives & Competitors

AVVie vs
NeoChord, Inc.
NeoChord, Inc. United States

Transforming Mitral Valve Repair

Convertible Note
20 employees
Biotechnology, Health Care
AVVie vs
MVRx, Inc.
MVRx, Inc.

Advanced transcatheter therapy for resilient heart health and optimal blood flow

Venture round
11-50 employees
Health Care, Health and Wellness

FAQ About AVVie

Advancing Transcatheter Mitral Valve Repair
AVVie was founded in 2018.
AVVie is headquartered in Austria.
AVVie operates in Health Care, Manufacturing and Medical Devices.
AVVie has approximately 9 employees.
Top alternatives and competitors to AVVie include NeoChord, Inc., MVRx, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
AVVie and NeoChord, Inc. are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for AVVie, https://bouncewatch.com/company/avvie, updated 8 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Book a demo 30 minutes